iris-pharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | Ophthalmic CRO - Preclinical & Clinical services | Iris |
| Description | Iris Pharma partners with you to carry out preclinical studies and clinical trials targeting ocular Iris Pharma, a Contract Research Organization, provides preclinical and clinical research in ophthalmology: ocular safety, efficacy, ocular pharmacokinetics, clinical trials, bioanalytical |
| Keywords | contract research organization, CRO, preclinical research, clinical research, iris pharma, irispharma, ophthalmology research, ocular safety, ocular pharmacokinetics |
Server Information
| WebSite | |
| Host IP | 213.186.33.105 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
iris-pharma.com Valuation
|
US$2,541,239
Last updated: 2023-05-11 14:11:43
iris-pharma.com has Semrush global rank of 4,165,017. iris-pharma.com has an estimated worth of US$ 2,541,239, based on its estimated Ads revenue. iris-pharma.com receives approximately 293,220 unique visitors each day. Its web server is located in France, with IP address 213.186.33.105. According to SiteAdvisor, iris-pharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,541,239 |
| Daily Ads Revenue | US$2,346 |
| Monthly Ads Revenue | US$70,373 |
| Yearly Ads Revenue | US$844,474 |
| Daily Unique Visitors | 19,548 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| iris-pharma.com. | A | 3600 | IP: 213.186.33.105 |
| iris-pharma.com. | NS | 300 | NS Record: ns2.tasfrance.com. |
| iris-pharma.com. | NS | 300 | NS Record: ns4.tasfrance.com. |
| iris-pharma.com. | NS | 300 | NS Record: ns1.tasfrance.com. |
| iris-pharma.com. | NS | 300 | NS Record: ns3.tasfrance.com. |
| iris-pharma.com. | MX | 3600 | MX Record: 0 irispharma-com01b.mail.protection.outlook.com. |
| iris-pharma.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=f5b1921f0a9221125585b170562f00b8aa55e84129c9382ec3e1e0f738bed549 |
| iris-pharma.com. | TXT | 3600 | TXT Record: v=spf1 ip4:194.250.12.138/32 include:spf.protection.outlook.com include:spf.mailjet.com include:cmail1.com include:mx.ovh.com -all |
| iris-pharma.com. | TXT | 3600 | TXT Record: google-site-verification=GBtM7yf2cmpuSk-6stWtpL2xGOYPZjzhXDfEJNO6m3Q |
| iris-pharma.com. | TXT | 3600 | TXT Record: apple-domain-verification=NRq83xRbsDub8zQ8 |
HtmlToTextCheckTime:2023-05-11 14:11:43
| Iris Pharma partners with you to carry out preclinical studies and clinical trials targeting ocular innovations. Facilitating Successful Development of your Ocular Therapies Discover more --> --> Early testing Preclinical development Clinical trials Clinical trials Contact About Iris Pharma Contact About Iris Pharma Home Early testing -- Efficacy & Proof of Concept -- Early Pharmacokinetics -- Pilot Tolerance & Safety Testing -- Formulation & Delivery Preclinical development -- In vivo Pharmacology Studies -- GLP Ocular Tolerance & Safety -- GLP Ocular Pharmacokinetics -- Equipment Clinical Trials -- Clinical Trial Services -- Ophthalmic Indications -- Clinical Trial Phases -- Countries About Iris Pharma -- Who We Are -- Why us -- Services -- Ocular Expertise -- Publications -- News & Media -- Events Contact Privacy policy Sitemap Congrès : news importantes --> THE SPECIALIST FOR YOUR OCULAR DRUG & MEDICAL DEVICE DEVELOPMENT --> Advancing your program with global, |
HTTP Headers
HTTP/1.1 301 Moved Permanently date: Thu, 04 Nov 2021 22:10:20 GMT content-type: text/html; charset=iso-8859-1 location: https://iris-pharma.com/ cache-control: max-age=7200 expires: Fri, 05 Nov 2021 00:10:20 GMT x-iplb-request-id: 894A7A04:6C3C_D5BA2112:0050_61845A4C_4B40:2B67E x-request-id: 428933405 vary: Accept-Encoding x-cdn-pop: bhs x-cdn-pop-ip: 137.74.122.0/26 x-cacheable: Cacheable x-iplb-request-id: D17E5643:9D32_D5BA2169:0050_61845A4C_00B6:B040 x-iplb-instance: 32161 HTTP/2 301 date: Thu, 04 Nov 2021 22:10:20 GMT content-type: text/html; charset=iso-8859-1 location: https://www.iris-pharma.com/ cache-control: max-age=7200 expires: Fri, 05 Nov 2021 00:10:20 GMT x-request-id: 404029762 vary: Accept-Encoding x-cdn-pop: bhs x-cdn-pop-ip: 137.74.122.0/26 x-cacheable: Cacheable content-length: 236 HTTP/2 200 date: Thu, 04 Nov 2021 22:10:21 GMT content-type: text/html; charset=UTF-8 cache-control: no-cache, no-store, no-cache, must-revalidate, post-check=0, pre-check=0 set-cookie: laravel_session=2ee8cd4dbfb4dd3250dd69dbf284481337e9978e%2Bwn6Bp5jgu6AzMFV6ZoETKisrWbL4K8WMV0rN79iU; expires=Thu, 04-Nov-2021 23:10:21 GMT; path=/; httponly expires: Fri, 05 Nov 2021 00:10:21 GMT vary: Accept-Encoding pragma: no-cache x-request-id: 965545860 x-cdn-pop: bhs x-cdn-pop-ip: 137.74.122.0/26 x-cacheable: Cacheable accept-ranges: bytes |
iris-pharma.com Whois Information
Domain Name: IRIS-PHARMA.COM Registry Domain ID: 3610290_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namebay.com Registrar URL: http://www.namebay.com Updated Date: 2017-04-06T08:27:47Z Creation Date: 1997-04-22T04:00:00Z Registry Expiry Date: 2022-04-23T04:00:00Z Registrar: Namebay SAM Registrar IANA ID: 88 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.TASFRANCE.COM Name Server: NS2.TASFRANCE.COM Name Server: NS3.TASFRANCE.COM Name Server: NS4.TASFRANCE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-02T07:37:25Z <<< |